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Abstract
Subcortical vascular dementia (SVaD), one of common causes of dementia, has concomitant Alzheimer’s disease (AD)
pathology in over 30%, termed ‘‘mixed dementia’’. Identifying mixed dementia from SVaD is important because potential
amyloid-targeted therapies may be effective for treatment in mixed dementia. The purpose of this study was to discriminate
mixed dementia from pure SVaD using magnetic resonance imaging (MRI). We measured brain amyloid deposition using
the 11C-Pittsburgh compound B positron emission tomography (PiB-PET) in 68 patients with SVaD. A PiB retention ratio
greater than 1.5 was considered PiB(+). Hippocampal and amygdalar shape were used in the incremental learning method
to discriminate mixed dementia from pure SVaD because these structures are known to be prominently involved by AD
pathologies. Among 68 patients, 23 (33.8%) patients were positive for PiB binding. With use of hippocampal shape analysis
alone, PiB(+) SVaD could be discriminated from PiB(-) SVaD with 77.9% accuracy (95.7% sensitivity and 68.9% specificity).
With use of amygdalar shape, the discrimination accuracy was 75.0% (87.0% sensitivity and 68.9% specificity). When
hippocampal and amygdalar shape were analyzed together, accuracy increased to 82.4% (95.7% sensitivity and 75.6%
specificity). An incremental learning method using hippocampal and amygdalar shape distinguishes mixed dementia from
pure SVaD. Furthermore, our results suggest that amyloid pathology and vascular pathology have different effects on the
shape of the hippocampus and amygdala.
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Introduction
Subcortical vascular dementia (SVaD) is one of common causes
of dementia [1], and is characterized by extensive white matter
hyperintensities (WMH) and multiple lacunes. Pathological studies
have demonstrated that some patients who have been clinically
diagnosed with SVaD also have co-associated Alzheimer’s disease
(AD) pathologies [2,3]. Thus, the concept of mixed dementia has
emerged. A recent study using the Pittsburgh compound B
positron emission tomography (PiB-PET) [4], a sensitive method
of detecting amyloid in fibrillary form, has shown that about 30%
of patients who have been clinically diagnosed with SVaD present
with significant amyloid burden, indicating that these patients
have mixed dementia [5].
There is a need to detect the presence of AD pathology in
subjects with clinical SVaD. Although there is considerable
overlap, mixed dementia and pure SVaD differ in terms of
clinical phenotype and treatment. A previous study indicated that,
clinically, patients with mixed dementia were older and performed
worse on memory tests than those with pure SVaD [5]. In regards
to treatment, patients with mixed dementia could potentially
benefit from future amyloid-targeted therapies while management
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of vascular risk factors and antiplatelet therapies may be more
focused in patients with pure SVaD.
Although amyloid PET and cerebrospinal fluid (CSF) studies
can detect concomitant amyloid burden in the brain, these
methods are limited in clinical practice in the following ways.
Primarily, the half-life of 11C, a radio ligand of PiB-PET, is only
20–30 minutes; while another amyloid PET, Amyvid (using
amyloid ligand 18F), has been approved by the United States Food
and Drug Administration [6], it is expensive and not yet widely
available. An alternative method can detect low amyloid beta 42
and high tau levels in CSF [7]. However, CSF studies are invasive
and results can vary among laboratories. Thus, it is important to
diagnose mixed dementia patients using widely available data such
as structural magnetic resonance imaging (MRI), before using
expensive or invasive tools.
It is well known that the medial temporal regions including
hippocampus and amygdala are structures that are atrophied in
patients with AD [8]. Pathological studies suggested that AD
pathology is involved in hippocampus and amygdala even in the
early stage [9]. Thus imaging analysis of these structures has
recently been used in research of AD [10–12]. Therefore it can be
assumed that concomitant AD pathology in SVaD may also give
rise to atrophy in the hippocampus and amygdala. Indeed, a
previous study has shown that by using a visual rating, mixed
dementia patients have demonstrated more severe hippocampal
atrophy than pure SVaD patients [5].
Characteristics of mixed dementia that differ from pure SVaD
have been proposed [5]. However, an individual subject classifi-
cation model rather than a group analysis would provide more
practical information to individual patients. Numerous classifica-
tion models have been suggested to discern between certain groups
in clinical practice. In general, clinical and imaging data have been
used to classify individual patients for diagnosis [13,14] or for
predicting disease progression [15,16]. Most classification models
have been based on the Alzheimer’s Disease Neuroimaging
Initiative dataset, and thus have focused on AD dementia and
its prodromal stage [14,15,17]. To our knowledge, there have
been no previous studies that have provided an individual subject
classification model to distinguish mixed dementia from pure
SVaD.
In this study, we aimed to discriminate mixed dementia from
pure SVaD by employing surface-based subcortical shape analysis
methods. Our methods combine MRI information that is typical
for AD, including changes in hippocampal and amygdalar shape.
Both hippocampal and amygdalar shape information were
combined to construct the feature vector in high-dimensional
space (i.e., more than 8000 dimensions). In order to effectively
reduce the feature data, we used a manifold harmonic transform
and principal component analysis (PCA), which facilitates
classification with high accuracy [16]. Furthermore, an incremen-
tal learning method [16] was used to train our classifier. MR
images are usually obtained during disease diagnosis and, thus, the
volume of data increases steadily, which justifies our classification
method based on incremental learning.
Methods
Ethics Statement
The study was approved by the Institutional Review Board of
the Samsung Medical Center. We obtained written informed
consent from all the participants. Structured written consent
procedures were used by research staff when approaching
participants with cognitive impairment. The assent of ‘‘next of
kin’’ was required for participation of people with cognitive
impairment who were unable to provide informed consent.
Participants
From September 2008 to August 2011 we prospectively
recruited 98 patients with SVaD. SVaD was determined using
the diagnostic criteria for vascular dementia as defined by the
Diagnostic and Statistical Manual of Mental Disorders–Fourth
Edition (DSM-IV). Patients were evaluated in a clinical interview
and neurological and neuropsychological examinations as previ-
ously described [18]. All SVaD patients had a significant ischemia
on their MRI scans, which was defined as having a cap or band of
$10 mm as well as a deep white matter lesion of $25 mm, as
modified from the Fazekas ischemia criteria [19]. We excluded
patients with territory infarctions and those with high signal
abnormalities on the MRI due to radiation injury, multiple
sclerosis, vasculitis, or leukodystrophy. We also excluded patients
who met Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition criteria for psychotic disorder or mood disorder
such as schizophrenia or major depressive disorder. In order to
exclude secondary causes of cognitive deficits, all patients
completed laboratory tests including a complete blood count,
blood chemistry, vitamin B12/folate, syphilis serology, and thyroid
function tests. Brain MRI scanning confirmed the absence of
structural lesions including territorial cerebral infarction, brain
tumor, hippocampal sclerosis, and vascular malformation.
Of the 98 SVaD patients, 70 patients completed a [11C] PiB-
PET scan. During the process of imaging analysis, an error
occurred in two patients. Thus a total of 68 patients were analyzed
in this study.
[11C] PiB-PET
All 70 patients completed the [11C] PiB-PET scan at Samsung
Medical Center or Asan Medical Center. All subjects completed
the same type of PETscan with a Discovery STe PET/computed
tomography scanner (GE Medical Systems, Milwaukee, WI, USA)
in a 3-D scanning mode that examined 35 slices of 4.25-mm
thickness that spanned the entire brain. The 11C-PiB was injected
into an antecubital vein as a bolus with a mean dose of 420 MBq
(range, 259e550 MBq). A computed tomography scan was
performed for attenuation correction at 60 minutes after the
injection. A 30-minute emission static PET scan was then initiated
[5].
PiB-PET images were coregistered to individual MRI scans,
which were normalized to a T1-weighted MRI template. Using
these parameters, MRI-coregistered PiB-PET images were nor-
malized to the MRI template. The quantitative regional values of
PiB retention on the spatially normalized PiB images were
obtained by an automated volume of interest (VOI) analysis using
the automated anatomical labeling atlas. Data processing was
performed using the SPM version 5 (SPM5) under Matlab 6.5
(Mathworks, Natick, MA, USA). To measure PiB retention, we
used the cerebral cortical region to cerebellum uptake ratio
which is identical to the standardized uptake value ratios (SUVRs).
The cerebellum was used as a reference region because it did not
show group differences. We selected 28 cortical VOIs from left
and right hemispheres using the automated anatomical labeling
atlas. The cerebral cortical VOIs which were chosen for this study
consisted of bilateral frontal (superior and middle frontal gyri,
medial part of the superior frontal gyrus, opercular part of the
inferior frontal gyrus, triangular part of the inferior frontal gyrus,
supplementary motor area, orbital part of the superior, middle,
and inferior orbital frontal gyri, rectus, and olfactory cortex),
posterior cingulate gyri, parietal (superior and inferior parietal,
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supramarginal and angular gyri, and precuneus), lateral temporal
(superior, middle, and inferior temporal gyri, and Heschl gyri), and
occipital (superior, middle, and inferior occipital gyri, cuneus,
calcarine fissure, and lingual and fusiform gyri). Regional cerebral
cortical SUVRs were calculated by dividing each cortical VOI’s
standardized uptake value by mean standardized uptake value of
the cerebellar cortex. Global PiB retention ratio was calculated
from the volume-weighted average SUVR of 28 bilateral cerebral
cortical VOIs [5]. A PiB retention ratio greater than 1.5 was
considered PiB(+).
MR imaging techniques
T2, T1, FLAIR and T2 Fast Field Echo (FFE) MR images were
acquired from 70 subjects with SVaD at the Samsung Medical
Center using the same 3.0 T MRI scanner (Philips 3.0T Achieva).
In all patients, these images were obtained in one session and all
MR images were obtained in the same orientation and slice
positions. FLAIR MR images were acquired in the axial plane
with the following parameters: axial slice thickness of 2 mm, no
gap; repetition time (TR) of 11000.0 ms; echo time (TE) of
125.0 ms; flip angle of 90u; and matrix size of 512x512 pixels. T2
Fast Field Echo (FFE) images were obtained using the following
parameters: axial slice thickness of 5.0 mm; inter-slice thickness of
2 mm; TR, 669 ms; TE 16 ms; flip angle of 18u; and matrix size of
5606560 pixels.
Our method aimed to classify mixed dementia from pure SVaD
by employing the following three steps: subcortical shape analysis,
multivariate classifier learning, and individual subject classifica-
tion. Figure 1 presents an overview of our method. Details of each
step are described in the following sections.
Shape analysis of subcortical structures
We performed shape analysis of subcortical structures by
measuring relative deformation of subcortical surface meshes
against the template mesh. The shape analysis process consists of
four steps: volume parcellation, surface extraction, registration,
and surface deformity computation (see Figure 1[a]). The first step
obtains the anatomical parcellations of human subcortical
structures from the T1 images of each patient using the FreeSurfer
software package (Version 5.0, Athinoula A. Martinos Center at
the Massachusetts General Hospital, Harvard Medical School;
http://www.surfer.nmr.mgh.harvard.edu/). The parcellated im-
ages were then transformed to native anatomical space for surface
extraction. The second step extracts surface meshes of the
subcortical structures for each subject by deforming the template
surface models. Specifically, we utilized the subcortical shape atlas
models [20] as a template surface and used the Laplacian-based
surface deformation method [21,22] in order to extract the
subcortical surfaces of each subject. The third step involved
surface registration in order to establish the vertex correspondence
of subcortical surface meshes across the sample. We used the
surface registration method developed by Cho et al. (2012) for
accurate registration. Finally, surface deformity of each subcortical
structure was measured against the template surface model by
calculating the vertex-wise spatial displacement along its outward
normal direction. In order to correct the brain size effect when
computing the shape deformity data, each subcortical surface
mesh was transformed from native anatomical space to the
template space using the inverse of the registration mapping.
In order to quantitatively validate our method for subcortical
surface construction, we performed a comparison test using
manually-delineated hippocampal volumes. An expert neuroanat-
omist manually delineated hippocampal volumes of 20 healthy
subjects from the T1 images slice-by-slice using version 4.2.2 of 3D
Slicer [23]. For the same set of healthy subjects, we extracted
hippocampal surface meshes using our surface construction
method described above. The hippocampal volume images were
then reverse-engineered from the reconstructed surface meshes by
superimposing the meshes on top of the input MR images. We
traversed every voxel of the input MR images, and tested if the
voxel is inside/outside the hippocampal surface mesh to construct
the hippocampal volume images. Finally, the volume overlap was
measured between the reverse-engineered volumes and the
manually delineated ones: we observed that the two hippocampal
volumes were overlapped for more than 90% of the manually-
parcellated volumes. This result shows that our Laplacian-based
surface modeling method [24,25] accurately constructs subcortical
surface meshes from the automatically-parcellated subcortical
volumes.
Multivariate classification using linear discriminant
analysis
Patterns of subcortical structure atrophies using MR structural
imaging have been utilized as significant biomarkers for the
diagnosis of Alzheimer’s disease (AD). In this study, we adopted
the incremental learning method proposed by Cho et al. (2012) to
analyze multivariate patterns of subcortical shape change that are
particularly useful in discriminating mixed dementia from pure
SVaD. The multivariate pattern analysis (MVPA) identifies
regions where spatially distributed patterns of subcortical shape
differences are evident between the two groups. In order to train
the multivariate classifier, we used linear discriminant analysis
(LDA) in combination with principal component analysis (PCA),
which was developed in machine learning to classify items based
on a linear separation in high-dimensional feature space [26–28].
LDA provides not only statistical measures of classification
accuracy, but also regional information about differences of two
groups based on how accurately or poorly they can be
discriminated with LDA.
Our multivariate pattern classification method consisted of two
steps: classifier training and individual subject classification (see
Figures 1[a] and [b]). The former step trained a classifier with
labeled MR volumes. We represented the shape deformity data of
subcortical structures for each subject in terms of their spatial
frequency components by using the manifold harmonic transform.
Specifically, for a surface mesh with m vertices, the shape
deformity data is represented using a m-dimensional vector X .
In our study, m~2562 for the hippocampal and amygdale surface
meshes. Then, the transformed vector X can be represented as
Xi~
Pm
i~1 xifi, where \fi is the ith eigenvector of the manifold
harmonic transform. This step then filtered out high frequency
components from the shape deformity data at vertices, which had
been extracted from the MR volumes in order to remove noise.
The resulting feature vector is now X
_
~(x1,x2,:::,xF ), where F is a
cut-off frequency: in our study, F~16, which was determined in a
similar manner to our previous study [16]. We then used PCA to
reduce the dimension of the feature space, which prevents the
singularity problem in performing LDA. We empirically decided
the dimension of the reduced feature space by setting the
percentage of the total variance to 70%. Finally, the classifier
was obtained by using LDA with the transformed training data ~Xi,
i~1,2,:::,N in the reduced PCA space. Among human subcortical
structures, shape deformities of both hippocampi and the
amygdala were used to represent high-dimensional features of
brain atrophy since those structures have been well known to be
substantially more vulnerable in AD.
SVaD Classifier
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The latter step classified unlabeled subjects by using an
individual subject classifier. This classifier was initialized with
the classifier trained in the previous step and incrementally
updated. Given the MR volume of a subject, the feature vector
representing the noise-filtered subcortical shape deformity data
was acquired, as in classifier training. Finally, the classifier
performed the multivariate classification using the high-dimen-
sional feature vector.
The LDA analysis between PiB(+) and PiB(-) SVaD was
completed using three different types of feature vectors: hippo-
campal shape deformity, amygdalar shape deformity, and their
combination. For each type of feature vector, we measured
classification accuracy and analyzed the multivariate patterns that
showed discriminative regions. Since different types of feature
vectors were given and standardized scores were not available, a
principal component analysis was performed separately to reduce
the number of dimensions to N eigenvectors, where N was the
minimum number of components that accounted for at least 70%
of the variance.
For assessment of classification performances, we performed a
10-fold, cross-validation procedure. We first trained three classi-
fiers for the PiB(+) versus PiB(-) SVaD classification using the three
different types of feature vectors. Specifically, for training a
classifier, we used 90% of the patients (those patients were selected
randomly from the total set of patients) as a training data set to
train the LDA-based multivariate classifier. We then used the
other 10% of the patients as test data for identifying their label and
for extracting multivariate patterns of subcortical shape change.
This process of training a classifier with 90% of the patients and
testing on the other 10% of the patients was repeated 10 times
until all patients had been used as test data at least once.
Prediction accuracy, sensitivity, specificity, and discriminative
regions were calculated.
In order to measure the prediction accuracy unbiased to a
specific ordering of the patients in the data sets, we generated 500
random permutations of all the training patients for each of the
training data for the three classifiers. For each permutation, we
measured the accuracy of the classifier using the corresponding
test patient data by incrementally updating the classifier; the
training data for 10 patients were iteratively supplied at a time for
incremental learning until all the training data were used.
Whenever the classifier was updated with the training patients,
all the test data were used to estimate the accuracy of the classifier.
We then measured the accuracy of the classifier with respect to the
number of used training data by averaging the results over all
permutations.
Our learning method was based on both PCA and LDA, which
train the classifier in an incremental manner. Specifically,
whenever a new data set was obtained, our classification method
trained the classifier incrementally with the newly obtained data
set. In contrast, conventional classification methods train the
classifier with an entire data set, including new data, in order to
additively reflect the new data, which is not much in general. Since
new data are obtained usually from the disease diagnosis stage, the
volume of data increases steadily. Under these circumstances, our
incremental learning-based classification method effectively ad-
dresses the problem of continued data acquisition at this stage.
Please refer to our previous paper [16] for more details of the
incremental learning-based classification method.
Identification of the discriminative regions
In order to analyze regional information about the differences
between PiB(+) and PiB(-) SVaD groups, we computed the
distinguishing regions that contributed to classifying the two
groups. LDA finds a separating axis w that maximally separates
groups for learning a classifier. The value of the ith component of
the vector w represents the contribution of the component to
classification. That is, if the value of the ith component of w is
zero, the ith element of every feature vector does not affect the
classification result. Conversely, if the value is larger than the
others, the classification result is more sensitive to the ith element
than the other elements. Therefore, the analysis of w provides the
discriminative region for classification. We visualized the axis w of
LDA by converting it to a pair of vectors on the left and right atlas
meshes. The w in the PCA space is first transformed to a vector in
the feature space. The vector is then divided into two parts:
frequency components for the left and right atlas meshes. These
frequency components are finally transformed to two subcortical
deformity vectors on the left and right atlas meshes, respectively.
We divided these vectors by their magnitudes to obtain two unit
vectors for visualization.
Statistics
We compared the demographic and clinical data among the
groups using Student t tests for continuous variables and Chi-
square tests for dichotomous variables.
Results
Clinical results
As shown in Table 1, PiB(+) SVaD and PiB(-) SVaD patients
showed significant differencies in age, number of lacunes, and
Apolipoprotein E (APOE) genotype. Patients with PiB(+) SVaD
were older, had fewer lacunes, and had more APOE4 carriers, as
compared to PiB(-) SVaD patients.
Multivariate classification results
To assess classification performances, we performed a 10-fold,
cross-validation procedure using the proposed LDA algorithm.
Table 2 shows the results using three different feature vectors:
hippocampal shape deformity, amygdalar shape deformity, and
the combination of the two shape deformities. We denote each of
the three feature vectors as feature 1, feature 2, and feature 3,
respectively, for simplification. The sensitivity and the specificity
were 95.7% and 68.9% for feature 1, 87.0% and 68.9% for feature
2, and 95.7% and 75.6% for feature 3, respectively (Figure 2(a)).
We further assessed the classification accuracy using leave-one-out
cross validation, which showed almost the same results for every
classifier. Figure 2(c) shows the ROC curve of each classifier. As
shown in these results, the performance of our classifier was
highest using the whole feature vectors (82.4% accuracy). In the
ROC curves, the AUC value for the classifier with feature 3 was
0.8203.
We further demonstrated the effectiveness of our incremental
classification method. For each of the feature vector, we measured
the accuracy of the classifier with respect to the number of patients
used in training data. Figure 2(b) depicts the accuracy of every
classifier. As shown in the figure, accuracy tended to converge with
that of the respective classifier trained with the entire training data
as the number of used training patients approached to that of the
Figure 1. Overview of the proposed classification method: (a) subcortical shape analysis, (b) multivariate classifier training, and (c)
individual subject classification.
doi:10.1371/journal.pone.0075602.g001
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training patients in the data set. We also extracted the
discriminative regions for our classifiers, which provided multi-
variate patterns contributing to the discriminability between the
mixed dementia and pure SVaD groups. Figure 3 depicts the
discriminative regions on the atlas surface meshes for our
classification. The anterior head, superior portion of body
subregions in the hippocampus and the lateral, medial, and
central subregions of the amygdala were the discriminative
regions.
Discussion
Using standard T1 weighed MRI, and incremental learning,
mixed dementia was distinguished from pure SVaD with 82.4%
accuracy. We found that hippocampal shape analysis alone was
able to classify mixed dementia from pure SVaD with 77.9%
accuracy (95.7% sensitivity and 68.9% specificity). Amygdalar
shape analysis was able to classify the two groups with75.0%
accuracy (87.0% sensitivity and 68.9% specificity). When both
hippocampi and amygdalar shape were incorporated into the
analysis, the classification accuracy increased to 82.4% (95.7%
sensitivity and 75.6% specificity).
Our individual analysis method has strengths in several aspects.
In general, nearby regions within a subcortex have correlated
brain functions and are similarly deformed by brain diseases. Our
method represents the subcortical deformity data of a subject in
terms of spatial frequency components by employing manifold
harmonic transform. Thus, the resulting feature vector exploits the
spatial coherency of the subcortical deformity data in both
learning and classification. The vertex-wise subcortical deformity
representation poorly reflects spatial relationship of the feature
data since it handles each element of the deformity data
independently. On the other hand, a method based on a region-
wise representation of the deformity exploits a single value in a
region as a feature by averaging all the deformity data in the
region, which therefore poorly reflects detailed spatial variation of
the deformity data. Our method combines the advantages of the
vertex- and region-based methods, while reducing their short-
comings.
It is noteworthy that hippocampal shape alone could discrim-
inate mixed dementia from pure SVaD with 77.9% accuracy.
Hippocampi are known to be involved in AD pathologies, and
hippocampal volume and shape show significant differences across
normal aging, amnestic mild cognitive impairment and AD
dementia patients [8,29]. However, recent studies indicate that
white matter lesions are also associated with hippocampal atrophy
[30] and that SVaD patients show hippocampal atrophy as well
[31,32]. Furthermore, a recent study from our research group
reports that pure SVaD showed significant hippocampal atrophy
and shape deformity [33]. In using our method of incremental
learning analysis, we found subregions that contributed to
discriminating between the two groups. The bilateral anterior
head and the medial portion of body of hippocampus (Blue in
Figure 3) distinguished mixed dementia from pure SVaD in an
opposite direction relative to the bilateral lateral portion of body of
hippocampus (yellow in Figure 3). That is, the combination of
inward deformities in Blue and outward deformities in Yellow
regions, respectively, determines the pattern of shape deformity
specific to a certain group in the high-dimensional feature space.
Additional information from the amygdalar shape analysis
increased the classification accuracy, both in sensitivity and
specificity. According to pathologic studies, the amygdala is one
of the brain structures that is involved in the early stages of AD [9].
In addition, MR volumetric studies repeatedly demonstrate
amygdalar atrophy in patients with AD dementia [34,35]. In a
study with AD patients, the most affected subregions were the
basolateral ventral medial (BLVM) nucleus, which is connected to
hippocampus, medial nucleus, and central nucleus [36]. In our
classification model, the amygdalar subregions that primarily
distinguished mixed dementia from pure SVaD were the right
dorsolateral, left dorsomedial, and bilateral ventro-central subre-
Table 1. Clinical characteristics of patients with PiB(-) and
PiB(+) SVaD.
PiB(-) (n =45) PiB(+) (n = 23) p
Demographics
Age 71.967.4 78.164.7 ,0.001
Gender, M:F 21:24 06:17 0.101
Education 8.364.8 9.165.5 0.523
Risk factors
Hypertention 36 (80%) 18 (78.3%) 1.000
Diabetes 11 (24.4%) 6 (26.1%) 0.882
Hyperlipidemia 20 (44.4%) 6 (26.1%) 0.141
Cognition
MMSE 21.464.7 18.764.9 0.036
CDR-SOB 6.063.8 6.563.8 0.61
MRI markers
WMH volume, ml 41.9615.6 45.5622.9 0.447
Total lacune, n 21.1618.3 7.066.9 ,0.001
Intracranial volume 1381.46134.3 1390.46155.1 0.804
APOE genotype
APOE4 carriers 9 (21.4%) 10 (43.5%) 0.062
Medication
Antipsychotics 1 (2.2%) 2 (8.7%) 0.219
Antidepressant 5 (11.1%) 2 (8.7%) 0.756
Anxiolytics 4 (8.9%) 4 (17.4%) 0.303
Abbreviations: PiB, Pittsburgh compound B; MMSE, Mini-Mental State
Examination; CDR-SOB, clinical dementia rating sum of boxes; WMH, white
matter hyperintensities; APOE4, Apolipoprotein E epsiolon 4.
doi:10.1371/journal.pone.0075602.t001
Table 2. Classification accuracy for the three different features.
Feature 1 Hippocampal Shape Feature 2 Amygdalar Shape Feature 1+Feature 2
Sensitivity 95.65% 86.96% 95.65%
Specificity 68.89% 68.89% 75.56%
Accuracy 77.94% 75.00% 82.35%
doi:10.1371/journal.pone.0075602.t002
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Figure 3. Discriminative regions in classification: (a) left hippocampus, (b) right hippocampus, (c) left amygdala, and (d) right
amygdala. Each figure visualizes the LDA axes on the atlas meshes.
doi:10.1371/journal.pone.0075602.g003
Figure 2. Accuracy of individual subject classifiers: (a) classifiers were trained using all entire training data and (b) the classifiers
were trained in an incremental manner. For incremental learning, averaged accuracies of individual subject classifiers were shown with respect
to the number of training subjects used. The average accuracy of each classifier tended to increase with the number of training subjects used. (c) the
ROC curves of each classifier are shown.
doi:10.1371/journal.pone.0075602.g002
SVaD Classifier
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gions as colored in yellow in Figure 3, and the right dorsomedial,
bilateral ventro-medial subregions as colored in blue in Figure 3.
Similarly to the result of hippocampal analysis, different patterns
of shape deformity in the blue and yellow colored areas discern
mixed dementia from pure SVaD.
In the current study, we hypothesized that AD pathology
involve predominantly in the hippocampi and amygdala, which in
turn leads to differentiation of mixed dementia from pure SVaD.
As shown in figure 3, the colored areas are the regions where it
discriminates mixed dementia from pure SVaD. However, strictly
speaking, it does not provide information about whether shape
deformities in those subregions are more specific to a certain
group.
In order to assess classifier performance, we further employed a
framework of permutation tests [37–39]. Performing 10-fold cross-
validation in our experiments, permutation tests were employed to
estimate the statistical significance of the classification accuracy.
Specifically, we randomly permuted the subject labels of the
training data prior to training. The permutation was repeated
10,000 times and the accuracy value of the trained classifier at
every permutation was chosen as the statistic, which in turn form a
null permutation distribution. The significance level was then
estimated over the null distribution by computing the percentile of
the accuracy value calculated by the classifier trained on the real
subject labels. We conducted this experiment for the classifier
using the Feature 3. The resulting p-value was 0.0002 indicating
that the classifier learned the relationship between the data and the
labels reliably.
This study has several limitations. First PiB-PET may not be
sufficiently sensitive to detect soluble amyloid oligomers or diffuse
amyloid plaques. Second, we were not able to detect neurofibril-
lary tangles. Thus, PiB(-) SVaD might not be true ‘pure’ SVaD.
Third, the specificity of each classification model was relatively low
compared to high sensitivity. It might be related to the fact that
shape features specific to pure SVaD are not salient enough to
discriminate pure SVaD from mixed dementia. Unbalanced
sample sizes could be another important factor for the low
specificity. In order to resolve the imbalance between specificity
and sensitivity, one may employ classification strategies consider-
ing trade-off between them [40]. Fourth, there were differences in
age between PiB(+) SVaD and PiB(-) SVaD. It might be related to
the fact that age is one of the most important risk factors of
amyloid pathology. Therefore, it might be further needed to
develop a new classification method that deals with the clinical
information. Another limitation of our method is that it requires
an empirical selection of two parameters: cut-off frequency F and
the dimension of the reduced PCA space. In our study, we used
the goodness of fit to determine the cut-off frequency F : we set the
goodness of fit to a bit conservative value and obtained F~16.
However, the accuracy of a classifier could be improved by
selecting optimal F in a classifier-specific manner. A similar
argument could be applied to the determination of the reduced
PCA space. Nevertheless, this is the first study to provide an
individual subject classifier to discriminate mixed dementia from
pure SVaD. Our classification method provides a useful tool for
classifying mixed dementia from pure SVaD with relatively high
accuracy, which has clinical implications for diagnosis and
treatment. There are numerous ongoing trials testing amyloid-
targeted therapies, whereas no potential disease modifying
therapies have emerged for cerebral ischemia. Thus with the use
of our classification model, mixed dementia patients may benefit
from amyloid-targeted therapies.
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